Canna-Global Acquisition (CNGL) Competitors

Canna-Global Acquisition (NASDAQ:CNGL) and Health Catalyst (NASDAQ:HCAT) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, earnings, dividends, profitability, risk, valuation, analyst recommendations and community ranking.

Do insiders and institutionals believe in CNGL or HCAT?

19.5% of Canna-Global Acquisition shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 72.1% of Canna-Global Acquisition shares are held by insiders. Comparatively, 2.5% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in CNGL or HCAT?

Health Catalyst received 163 more outperform votes than Canna-Global Acquisition when rated by MarketBeat users.

Company	Underperform	Outperform
Canna-Global Acquisition	N/A	N/A
Health Catalyst	Outperform Votes 163 67.08%	Underperform Votes 80 32.92%

Does the media favor CNGL or HCAT?

In the previous week, Health Catalyst had 15 more articles in the media than Canna-Global Acquisition. MarketBeat recorded 15 mentions for Health Catalyst and 0 mentions for Canna-Global Acquisition. Health Catalyst's average media sentiment score of 0.39 beat Canna-Global Acquisition's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the news media.

Company	Overall Sentiment
Canna-Global Acquisition	Neutral
Health Catalyst	Neutral

Do analysts recommend CNGL or HCAT?

Health Catalyst has a consensus price target of $8.73, suggesting a potential upside of 127.27%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts clearly believe Health Catalyst is more favorable than Canna-Global Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canna-Global Acquisition	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Health Catalyst	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70

Is CNGL or HCAT more profitable?

Canna-Global Acquisition has a net margin of 0.00% compared to Health Catalyst's net margin of -26.20%. Canna-Global Acquisition's return on equity of 0.00% beat Health Catalyst's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canna-Global Acquisition	N/A	N/A	N/A
Health Catalyst	-26.20%	-7.51%	-3.72%

Which has more risk & volatility, CNGL or HCAT?

Canna-Global Acquisition has a beta of -0.02, indicating that its stock price is 102% less volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500.

Which has higher valuation and earnings, CNGL or HCAT?

Canna-Global Acquisition has higher earnings, but lower revenue than Health Catalyst.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canna-Global Acquisition	N/A	N/A	N/A	N/A	N/A
Health Catalyst	$306.58M	0.88	-$118.15M	-$1.15	-3.34

Summary

Health Catalyst beats Canna-Global Acquisition on 9 of the 13 factors compared between the two stocks.